BioLife Solutions price target lowered to $27 from $29 at H.C. Wainwright

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on BioLife Solutions (BLFS) to $27 from $29 and keeps a Buy rating on the shares post the Q3 report. The company’s divestiture is completed for all freezer and related businesses, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue